ZIMMERMANN MARTINE sold 23.5% of their position (1.20K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $342.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2026ACC: 0002001011-26-000140
Director
Since Sep 2023
-1.20K
Net shares
Net seller
$342.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.20K
Price / share
$285.00
Trade value
$342K
% of position
23.5%
9/10/2026
5.10K→3.90K
Total
Net shares
−1.20K
Net value
-$342K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | S · Sale | −1.20K | $285.00 | $342K | 23.5% | 5.10K | 3.90K |
| Total | −1.20K | -$342K | ||||||
Derivative Transactions0
No derivative transactions reported